1. Home
  2. |Insights
  3. |DoD Issues Long-Awaited Interim Rule on Cyber Requirements and Cloud Services

DoD Issues Long-Awaited Interim Rule on Cyber Requirements and Cloud Services

Client Alert | 1 min read | 09.03.15

As discussed in our recent blog post, on August 26, DoD published an Interim Rule that would expand the already onerous requirements of the DFARS Safeguarding Clause by broadening its application to "covered defense information" and by requiring subcontractors to report cyber incidents directly to DoD. As discussed in a separate blog post, the Interim Rule also seeks to ensure uniformity in the DoD's IT acquisition and use of cloud computing services by adding T&C's, including that, unless otherwise authorized, cloud service providers must maintain all government data within the U.S., outlying areas, or DoD premises.


Contacts

Insights

Client Alert | 7 min read | 09.14.26

AI in Life Sciences: Ten Legal Considerations and Risks of AI Use in Drug Discovery and Development

Over the past several years, the biopharmaceutical industry has embraced artificial intelligence and machine learning (AI/ML) in near lockstep with the pace of AI/ML innovations. Today, industry leaders are using AI/ML to, among other things: discover and assess biological pathways, target chemical structures and sequences; design proteins; model pre-clinical and clinical trials; recruit and screen potential patient populations; evaluate clinical trial results and biomarker data; prepare regulatory filings; and manage supply chains. Deployment of new AI/ML models promises extraordinary advances in pharmaceutical development. However, as with any technological and scientific advances, the use of AI/ML also poses substantial legal risks that life sciences companies need to consider and proactively manage. ...

View All Insights